The Economic Burden of Inflammatory Bowel Disease: Clear Problem, Unclear Solution

Direct Health Care Insurer and Out-of-Pocket Expenditures of Inflammatory Bowel Disease: Evidence from a US National Survey

(2012) Candace Gunnarsson et al.   DIGESTIVE DISEASES AND SCIENCES

Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States

(2010) K. T. Park et al.   INFLAMMATORY BOWEL DISEASES

The pharmacoeconomics of biologic therapy for IBD

(2010) Russell D. Cohen   Nature Reviews Gastroenterology & Hepatology

Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study

(2008) Brian G. Feagan et al.   GASTROENTEROLOGY

Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults

(2008) Michael D. Kappelman et al.   GASTROENTEROLOGY

How expensive is inflammatory bowel disease? A critical analysis

(2008) Selwyn Odes   WORLD JOURNAL OF GASTROENTEROLOGY